ABBV

AbbVie Inc primary

281.09

+4.64+1.7%

as of 2026-10-12

Days to earnings14

Next print2026-10-30

WindowBMO

Fiscal2026-09-30

Consensus EPS3.844

Consensus revenue17.3B

EPS high / low3.87 / 3.773 · 2.5% · n=19

Rev / avg1 / — · 3.844 / 3.844

IV front25.9%

Implied move5.7%

Put/call full0.82

Put/call front0.91

Short shares16.3M / 19.5M · -16.49%

Days to cover4.14

Avg vol · float3.9M · 1.8B

Short % float0.92%

Date	DTE	Next	Close	Cons. EPS	IV front %	Implied	Ret 5d	Ret 10d	Ret 20d	Ret 30d	EPS high / low	Dispersion	Analysts	P/C
2026-10-12	14	2026-10-30	281.09	3.844	25.9%	5.7%	+5.8%	+5.6%	+7.4%	+10.0%	3.87 / 3.773	2.5%	19	0.82
2026-10-09	15	2026-10-30	276.45	3.844	28.8%	6.9%	+5.2%	+4.6%	+7.5%	+7.1%	3.87 / 3.773	2.5%	19	0.82
2026-10-08	16	2026-10-30	272.42	3.844	26.4%	6.5%	+4.8%	+2.8%	+6.8%	+3.6%	3.87 / 3.773	2.5%	19	0.83
2026-10-07	17	2026-10-30	271.31	3.844	25.4%	6.4%	+3.7%	+2.4%	+8.1%	+2.1%	3.87 / 3.773	2.5%	19	0.83
2026-10-06	18	2026-10-30	266.76	3.844	26.4%	6.8%	+1.3%	+0.6%	+7.2%	+0.8%	3.87 / 3.773	2.5%	19	0.84
2026-10-05	19	2026-10-30	265.77	3.844	24.9%	6.5%	-0.2%	+0.5%	+3.6%	+0.3%	3.87 / 3.773	2.5%	19	0.84
2026-10-02	20	2026-10-30	262.90	3.845	25.9%	7.2%	-0.5%	-0.4%	+1.0%	+0.4%	3.87 / 3.773	2.5%	18	0.83
2026-10-01	21	2026-10-30	259.99	3.845	26.4%	7.4%	-1.9%	-1.5%	-0.7%	-2.2%	3.87 / 3.773	2.5%	18	0.83
2026-09-30	22	2026-10-30	261.78	3.845	26.4%	7.6%	-1.2%	-0.3%	+0.7%	+1.1%	3.87 / 3.773	2.5%	18	0.82
2026-09-29	23	2026-10-30	263.36	3.845	26.9%	7.8%	-0.7%	+0.1%	+2.7%	+5.2%	3.87 / 3.773	2.5%	18	0.82

Linked names and their last print

Peer	Name	Score	Last qtr	Last surprise	Reaction	1-day close	DTE (full)
JNJ primary	Johnson & Johnson	0.49	2026Q2 · 2026-07-15	+2.1%	-1.5%	247.02	1 · 2026-10-12
MRK primary	Merck & Company Inc	0.46	2026Q2 · 2026-08-04	+50.0%	+0.5%	128.00	13 · 2026-10-12
PFE primary	Pfizer Inc	0.41	2026Q2 · 2026-08-04	+13.2%	+0.0%	25.41	16 · 2026-10-12
LLY primary	Eli Lilly and Company	0.38	2026Q2 · 2026-08-05	+39.4%	+5.2%	1,169.86	13 · 2026-10-12

Fiscal qtr	Report date	Window	Actual EPS	Surprise %	Beat	Reaction	1-day result	Vol ×10d	Post 10d	Review
2026Q2	2026-07-31	BMO	3.65	+0.3%	Beat	-1.9%	-0.6%	1.34×	-0.6%	Review
2026Q1	2026-04-29	BMO	2.65	-0.7%	Miss	-2.9%	+6.2%	1.49×	+2.3%	Review
2025Q4	2026-02-04	BMO	2.71	+2.3%	Beat	-7.0%	+3.5%	2.27×	+3.3%	Review
2025Q3	2025-10-31	BMO	1.86	+4.5%	Beat	-2.3%	-2.2%	2.37×	+6.6%	Review
2025Q2	2025-07-31	BMO	2.97	+2.1%	Beat	+4.1%	-4.1%	2.22×	+8.3%	Review
2025Q1	2025-04-25	BMO	2.46	+2.5%	Beat	+3.7%	-0.6%	1.22×	-0.8%	Review
2024Q4	2025-01-31	BMO	2.16	+1.9%	Beat	+6.6%	-1.8%	1.85×	+4.9%	Review
2024Q3	2024-10-30	BMO	3.00	+2.7%	Beat	+1.1%	+5.2%	2.04×	-15.5%	Review
2024Q2	2024-07-25	BMO	2.65	-0.4%	Miss	+0.4%	+2.9%	2.13×	+4.5%	Review
2024Q1	2024-04-26	BMO	2.31	+3.6%	Beat	-0.1%	-4.5%	2.09×	+0.7%	Review

Snapshot